Dysfunctional microvasculature as a consequence of Shb gene inactivation causes impaired tumor growth

Cancer Research

Volumn 69, Issue 5, 2009, Pages 2141-2148

  Funa, Nina S ^a   Kriz, Vitezslav ^b   Zang, Guangxiang ^a,c   Calounova, Gabriela ^a,d   Åkerblom, Björn ^a   Mares, Jaroslav ^d   Larsson, Erik ^a   Sun, Ying ^e   Betsholtz, Christer ^e   Welsh, Michael ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b MASARYK UNIVERSITY   (Czech Republic)

^c JILIN UNIVERSITY   (China)

^d CHARLES UNIVERSITY   (Czech Republic)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CD31 ANTIGEN; LEUKOCYTE ANTIGEN; ONCOPROTEIN; SHB PROTEIN, MOUSE; VASCULAR ENDOTHELIAL CADHERIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER INHIBITION; CELL ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSKELETON; ENDOTHELIUM; ENDOTHELIUM CELL; FEMALE; GENE; GENE FUNCTION; GENE INACTIVATION; HEART MUSCLE CAPILLARY; KNOCKOUT MOUSE; LIVER SINUSOID; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHB GENE; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VASCULARIZATION; ULTRASTRUCTURE; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; EXPERIMENTAL NEOPLASM; GENETICS; HEART MUSCLE; LIVER; PATHOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD31; CADHERINS; CAPILLARY PERMEABILITY; ENDOTHELIAL CELLS; LIVER; MICE; MICE, INBRED C57BL; MYOCARDIUM; NEOPLASMS, EXPERIMENTAL; PROTO-ONCOGENE PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 62449083531     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3797     Document Type: Article

References (49)

1. Doetsch F. A. niche for adult neural stem cells. Curr Opin Genet Dev 2003;13:543-550
2. Shen Q, Goderie SK, Jin L et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 2004;304:1338-1340
3. Lammert E, Cleaver O, Melton D. Induction of pancreatic differentiation by signals from blood vessels. Science 2001:294:264-267.
4. Olsson AK, Dlmberg A, Kreuger J Claesson-Welsh L. VEGF receptor signalling-in control of vascular function. Nat Rev MoI Cell Biol 2006;7:359-371
5. Carmeliet P, Ferreira V Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435-439
6. Ferrara N, Carver-Moore K, Chen H, et al. Heterozy-gous embryonic lethality induced by targeted inactiva-tion of the VEGF gene. Nature 1996;380:439-442
7. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis In Fl.k-.1-deflcient mice. Nature 1995;376:62-66
8. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-985
9. Nagy JA, Feng D, Vasile E, et al. Permeability properties of tumor surrogate blood vessels induced by VEGF-A. Lab Invest 2006;86:767-780
10. Kamba T Tarn BY Hashlzume H et al. VEGF-dependent plasticity of fenestrated capillaries in. the normal adult microvasculature. Am J Physiol Heart Circ Physiol 2006;290:H560-76.
11. Karlsson T, Songyang Z, Landgren E, et al. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyroslne residues, tyrosine kinase recep-tors and Src homology 3 domain, proteins. Oncogene 1995;10:1475-1483
12. Cross MJ, Lu L, Magnusson P, et al. The Shb adaptor protein binds to tyrosine 766 in the FGFR-I and regulates the Ras/MEK/MAPK. pathway via FRS2 phosphorylation in endothelial cells. MoI Biol Cell 2002;13:2881-2893
13. Holmqvist K, Cross MJ, Rolny C, et al. The adaptor protein slib binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. J Biol Chem 2004;279:22267-75.
14. Hooshmand-Rad R, Lu L Heldin CH Claesson-Welsh L Welsh M. Platelet-derived growth factor-mediated signaling through the Shb adaptor protein: effects on cytoskeletal organization. Exp Cell Res 2000; 257:245-254
15. Holmqvlst K, Cross M Riley D Welsh M. The Shb adaptor protein, causes Src-dependent cell spreading and activation of focal adhesion kinase in murine brain endothelial, cells. Cell Signal 2003:15:171-179
16. Hagerkvist R, Mokhtari D, Lindholm C, et al. Consequences of Shb and c-Abl interactions for cell death in response to various stress stimuli. Exp Cell Res 2007;313:284-291
17. Anneren C, Llndholm CK, Kriz V, Welsh M. The FRK/ RAK-SHB signaling cascade: a versatile signal-transduc-tion pathway that regulates cell survival, differentiation and proliferation. Curr MoI Med 2003;3:313-324
18. Dixelius J, Larsson H, Sasaki T, et al. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 2000;95:3403-3411
19. Claesson-Welsh L Welsh M Ito N et al. Angiostatin. induces endothelial cell apoptosis and activation of focal adhesion kinase Independently of the integrin-binding motif RGD. Proc Natl Acad Sd USA. 1998;95:5579-5583
20. Lu L, Holmqvist K Cross M Welsh M. Role of the Src homology 2 domain-containing protein Shb in murine brain endothelial cell proliferation and differentiation. Cell Growth Differ 2002:13:141-8.
21. Rolny C, Lu L, Agren N, et al. Shb promotes blood vessel formation In embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-β signaling. Exp Cell Res 2005;308:381-93.
22. Lindholm CK IL-2 receptor signaling through the Shb adapter protein in T and NK cells. Biochem Biophys Res Commun 2002;296:929-936
23. Fuña NS, Reddy K, Bhandarkar S, et al. Shb gene knockdown increases the susceptibility of SVR endo-thelial tumor cells to apoptotic stimuli in vitro and in vivo. J Invest Dermatol 2008:128:710-716
24. Kriz V Mares J, Wenteel P, et al. Shb null allele is inherited with a transmission ratio distortion and causes reduced viability in utero. Dev Dyn. 2007;236: 2485-2492
25. Jones CE, Lee CT, Skinner W, Koyama P1 Prescott D. Absence of generalized immunosuppression in C57BL/ 6J mice implanted with Lewis T241 fibrosarcoma or Lewis lung carcinoma. Cancer Immunol Immunother 1984;18:82-86
26. Yamaura T, Doki Y, Murakami K, Saiki I. Model for mediastinal lymph node metastasis produced by orthotopic intrapulmonar)-implantation of lung cancer cells in. mice. Hum Cell 1999:12:197-204.
27. McEver RP, Moore KL, Cummings RD. Leukocyte trafficking mediated by selectin-carbohydrate interactions. J Biol Chem 1995;270:11025-11028
28. Greaves DR, Gordon S. Macrophage-specific gene expression: current paradigms and future challenges. Int J Hematol 2002;76:6-15.
29. Breviario F, Caveda L, Corada M, et al. Functional properties of human vascular endothelial Cadherin (7B4/cadherin-5), an endothelium-specific Cadherin. Arterioscler Thromb Vase Biol 1995:15:1229-1239
30. Cavallaro U, Llebner S, Dejana E. Endothelial Cadherins and tumor angiogenesis. Exp Cell Res 2006; 312:659-667.
31. Chrzanowska-Wodnicka M, Burridge K. Rhostimulated contractility drives the formation of stress fibers and focal adhesions. J Cell BIoI 1996:133:1403-15.
32. Amano M Ito M Kimura K et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem.1996;271:20246-20249
33. Amano M, Mukai H, Ono Y, et al. Identification of a putative target for Rho as the serine-threonine kinase protein kinase N. Science 1996;271:648-650
34. Kimura K, Ito M, Amano M, et al. Regulation of myosin, phosphatase by Rho and Rho-assoclated kinase (Rho-kinase). Science 1996;273:245-248
35. Carmeliet P, Lampugnani MG, Moons L, et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 1999:98: 147-157
36. Drab M Verkade P, Elger M et al. Loss of caveolae, vascular dysfunction, and pulmonary defects In caveo-lin-1 gene-disrupted mice. Science 2001;293:2449-2452
37. Catteilno A, Llebner S, Gallini R, et al. The conditional inactivation of the ß-catenin gene in endothelial cells causes a defective vascular pattern and Increased vascular fragility. J Cell Biol 2003:162: 1111-1122
38. Weis S, Cui J, Barnes L, Cheresh D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation, and metastasis. J Cell Biol 2004;167:223-229
39. Weis SM, Lindquist JN, Barnes LA, et al. Cooperation between VEGF and ß3 integrin during cardiac vascular development. Blood 2007:109:1962-1970.
40. Robinson SD, Reynolds LE, Wyder L, Hicklin DJ, Hodivala-Dllke KM. ß3-lntegrin regulates vascular endothelial growth factor-A-dependent permeability. Arterioscler Thromb Vase Biol 2004;24:2108-2114
41. Simionescu M. Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler Thromb Vase Biol 2007;27:266-274
42. Hellstrom M Gerhardt H Kalen M et al. Lack, of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 2001;153:543-553
43. Weis S, Shintani S, Weber A, et al. Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 2004;113:885-894
44. Vestweber D. VE-Cadherin. The Major Endothelial Adhesion Molecule Controlling Cellular Junctions and Blood Vessel Formation. Arterioscler Thromb Vase Biol 2008;28:223-232
45. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular per-meability. MoI CeU 1999;4:915-924
46. Matsumoto T, Turesson I Book. M Gerwins P Claesson-Welsh L. p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentia-tion in FGF-2-stlmulated angiogenesis. J Cell Biol 2002; 156:149-160
47. Lamallce L Houle F Huot J. Phosphorylation of Tyrl214 within VEGFR-2 triggers the recruitment of Nek and activation, of Fyn leading to SAPK2/p38 activation and endothelial, cell migration, in response to VEGF. J Biol Chem 2006:281:34009-34020
48. Phung TL, Ziv K, Dabydeen D, et al. Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. Cancer Cell 2006:10: 159-70.
49. Eriksson A, Cao R Roy J et al. Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestra-tions and vascular permeability. Circulation 2003;107: 1532-8.